Impact of interventions on the quality of life of cancer patients: a systematic review and meta-analysis of longitudinal research

被引：0

作者：

Long Bao Nguyen

Linh Gia Vu

Thanh Thien Le

Xuan Thanh Nguyen

Nam Gia Dao

Duy Cao Nguyen

Trang Huyen Thi Dang

Thuc Minh Thi Vu

Laurent Boyer

Guillaume Fond

Pascal Auquier

Carl A. Latkin

Melvyn W.B. Zhang

Roger C.M. Ho

Cyrus S.H. Ho

机构：

[1] Hanoi Medical University,Institute for Preventive Medicine and Public Health

[2] Duy Tan University,Institute for Global Health Innovations

[3] Duy Tan University,Faculty of Medicine

[4] Tufts University,Department of Biomedical Engineering

[5] Hue Central General Hospital,Research Centre on Health Services and Quality of Life

[6] Institute of Health Economics and Technology (iHEAT),Department of Psychological Medicine, Yong Loo Lin School of Medicine

[7] Aix Marseille University,Institute for Health Innovation and Technology (iHealthtech)

[8] Bloomberg School of Public Health,undefined

[9] Johns Hopkins University,undefined

[10] Lee Kong Chian School of Medicine,undefined

[11] Nanyang Technological University Singapore,undefined

[12] National University of Singapore,undefined

[13] National University of Singapore,undefined

来源：

Health and Quality of Life Outcomes | / 21卷

关键词：

Quality of life; HRQL; Cancer; Interventions;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

The impact of cancer interventions has been conducted in several research due to the significant burden of this non-communicable disease. The interventions that played an important role in the improvement of the patient’s quality of life (QoL) and health-related quality of life (HRQL) can be classified into two main groups: pharmaceutical and non-pharmacological methods. However, studies so far often analyze a specific group of interventions for specific types of cancer. Thus, in this systematic review and meta-analysis, we synthesized the overall impact of cancer interventions on patients’ quality of life in several cancers.

引用

共 30 条

[1]

Parkin DM(1994)Cancer in developing countries Cancer Surv 19–20 519-61

[2]

Moore MA(2010)Cancer epidemiology in mainland South-East Asia - past, present and future Asian Pac J Cancer Prev 11 67-80

[3]

Moore MA(2014)Cancer control programs in East Asia: evidence from the international literature J Prev Med Public Health 47 183-200

[4]

Cancer C(2018)Global, Regional, and National Cancer incidence, mortality, years of Life Lost, Years lived with disability, and disability-adjusted life-years for 29 Cancer groups, 1990 to 2016: a systematic analysis for the global burden of Disease Study JAMA Oncol 4 1553-68

[5]

Pinsky PF(2015)Principles of Cancer Screening Surg Clin North Am 95 953-66

[6]

Smith RA(2018)Cancer screening in the United States, 2018: a review of current American Cancer Society guidelines and current issues in cancer screening CA Cancer J Clin 68 297-316

[7]

Devlin EJ(2017)Cancer Treatment Side Effects: a Meta-analysis of the relationship between response expectancies and experience J Pain Symptom Manage 54 245-58

[8]

Denson LA(2017)Physiotherapy programme reduces fatigue in patients with advanced cancer receiving palliative care: randomized controlled trial Support Care Cancer 25 2899-908

[9]

Whitford HS(2021)A systematic review and meta-analysis of treatment-related toxicities of curative and palliative radiation therapy in non-small cell lung cancer Sci Rep 11 5939-76

[10]

Pyszora A(2018)Health-related quality of life in asian patients with breast cancer: a systematic review BMJ Open 8 e020512-76

← 1 2 3 →